Sirion Biotech GmbH. (10/6/20). "Press Release: Mustang Bio Licenses LentiBOOST Technology from Sirion Biotech for the Development of MB-207 Lentiviral Gene Therapy". Worcester, MA & Martinsried. |
2020-10-06 |
High-Tech Gründerfonds Management GmbH. (10/5/20). "Press Release: btov Partners, HV Holtzbrinck Ventures and HTGF Invest in Real World Evidence and Patient-reported Outcomes. 5 Million Euros for Heartbeat Medical". |
2020-10-05 |
Kaleido Biosciences, Inc.. (10/1/20). "Press Release: Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer". Lexington, MA. |
2020-10-01 |
High-Tech Gründerfonds Management GmbH. (10/1/20). "Press Release: Neuromodulation Pioneer Wise Closes EUR 15M Series C Financing Round to Launch Second Product, SCS EXPERT, for Chronic Pain". |
2020-10-01 |
ECBF Management GmbH. (10/1/20). "Press Release: New European Circular Bioeconomy Fund Is Ready to Invest in Europe's Transition to a more Sustainable Economy". Bonn. |
2020-10-01 |
MorphoSys AG. (9/30/20). "Press Release: MorphoSys Announces Departure of Jens Holstein, CFO, by Year End 2020". Planegg. |
2020-09-30 |
Bruker Corporation. (9/30/20). "Press Release: Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies". Billerica, MA. |
2020-09-30 |
BrainRepair UG. (9/30/20). "Press Release: Regulatory Breakthrough for BrainRepair UG Start-up – Stem Cell Treatment for Newborns". Bochum. |
2020-09-30 |
CureVac N.V.. (9/29/20). "Press Release: CureVac Initiates Phase 2a Clinical Trial of COVID-19 Vaccine Candidate. Study Conducted in Peru and Panama". Tübingen & Boston, MA. |
2020-09-29 |
Merck KGaA. (9/28/20). "Press Release: Stefan Oschmann to Hand Over Chair of Executive Board to Belén Garijo in 2021". Darmstadt. |
2020-09-28 |
Kymos S.L.. (9/28/20). "Press Release: Kymos and Prolytic Merge to Become Kymos Group". Barcelona & Frankfurt a.M.. |
2020-09-28 |
Ipsen S.A.. (9/25/20). "Press Release: Ipsen Appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Business Officer". Paris. |
2020-09-25 |
Libra Therapeutics, Inc.. (9/23/20). "Press Release: Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases". San Diego, CA. |
2020-09-23 |
Minaris Regnerative Medicine GmbH. (9/23/20). "Press Release: Hitachi Chemical’s Global Regenerative Medicine Business Renamed Minaris Regenerative Medicine". Allendale, NJ, Munich & Yokohama. |
2020-09-23 |
Chr. Hansen Holding A/S. (9/22/20). "Press Release: Chr. Hansen Acquires Jennewein Biotechnologie GmbH to Enter and Lead the High-growth Human Milk Oligosaccharides Market". |
2020-09-22 |
Medigene AG. (9/22/20). "Press Release: Strategic Measures including Restructuring with Extension of Cash Runway and Improved EBITDA". Planegg. |
2020-09-22 |
T-Knife GmbH. (9/21/20). "Press Release: T-Knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy". Berlin & Somerset, NJ. |
2020-09-21 |
Glycotope GmbH. (9/21/20). "Press Release: DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic Antibody Platforms". Leiden & Berlin. |
2020-09-21 |
Theolytics Ltd.. (9/21/20). "Press Release: Theolytics Announces Appointment of Immatics' Carsten Reinhardt to its Board of Directors". Oxford. |
2020-09-21 |
GeneWerk GmbH. (9/21/20). "Press Release: GeneWerk Announces Growth Equity Investment from Ampersand Capital Partners". |
2020-09-21 |
BioNTech SE. (9/17/20). "Press Release: BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021". Mainz. |
2020-09-17 |
Boehringer Ingelheim. (9/17/20). "Press Release: Boehringer Ingelheim and Mirati Therapeutics Annonce Clinical Collaboration to Study BI 1701963, a SOS1::pan-KRAS Inhibitor in Combination with MRTX849, a KRAS G12C Selective Inhibitor". Ingelheim & San Di |
2020-09-17 |
Infarm – Indoor Urban Farming GmbH. (9/17/20). "Press Release: Infarm Raises $170M during Pandemic to Grow Largest Urban Vertical Farming Network in the World". Berlin. |
2020-09-17 |
BioNTech SE. (9/15/20). "Press Release: BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162". Mainz. |
2020-09-15 |
4SC AG. (9/11/20). "Press Release: 4SC and Maruho Discontinue Collaboration for Development of 4SC’s Kv1.3 Inhibitors". Planegg-Martinsried. |
2020-09-11 |
Boehringer Ingelheim. (9/11/20). "Press Release: Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia". Ingelheim & New |
2020-09-11 |
Bayer AG. (9/10/20). "Press Release: Bayer – Supervisory Board Extends CEO Werner Baumann’s Contract until the End of April 2024. Company also Announces Progress in Roundup Settlements". Leverkusen. |
2020-09-10 |
Bayer AG. (9/9/20). "Press Release: Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases". Berlin & Salt Lake City, UT. |
2020-09-09 |
Bayer Pharmaceuticals Corporation. (9/9/20). "Press Release: Bayer Completes Acquisition of the UK-based Biotech Company Kandy Therapeutics Ltd.". Whippany, NJ. |
2020-09-09 |
Vibalogics GmbH. (9/8/20). "Press Release: Vibalogics Appoints Global CEO to Lead U.S. Expansion". |
2020-09-08 |
IcanoMab GmbH. (9/7/20). "Press Release: IcanoMab GmbH Founded with Private Funding to Develop Precision Canonical Monoclonal Antibodies in Oncology, Immune-Modulation, Acute Inflammation and Most Urgently for Covid-19". Polling. |
2020-09-07 |
CMS. (9/7/20). "Pressemitteilung: CMS begleitet Gründer des KI Start-ups Semalytix bei Serie-A Finanzierungsrunde". Berlin. |
2020-09-07 |
Boehringer Ingelheim. (9/7/20). "Press Release: Boehringer Ingelheim Discontinues Development of BI 1467335 for Diabetic Retinopathy". Ingelheim & Sydney. |
2020-09-07 |
Evotec SE. (9/2/20). "Press Release: Evotec Expands Its Proprietary Patient Database into Liver Disease with Unique Access to QUOD Biobank". Hamburg. |
2020-09-02 |
BiomX Inc.. (9/2/20). "Press Release: BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for Inflammatory Bowel Disease". Ness Ziona. |
2020-09-02 |
Merck KGaA. (9/2/20). "Press Release: Merck Places Hybrid Bond Amounting to €1.0 billion". Darmstadt. |
2020-09-02 |
Priavoid GmbH. (9/1/20). "Press Release: Philipp Bürling Appointed CEO of Priavoid". |
2020-09-01 |
Semalytix GmbH. (8/31/20). "Press Release: Semalytix Closes Series A Investment Totaling €4.3m". |
2020-08-31 |
High-Tech Gründerfonds Management GmbH. (8/28/20). "Press Release: Aignostics Raises €5m Seed Round to Advance AI-powered Pathology". |
2020-08-28 |
Bayer AG. (8/27/20). "Press Release: Bayer Receives Approval for Xofigo in China [Not intended for U.S. and UK Media]". Berlin. |
2020-08-27 |
Autifony Therapeutics Ltd.. (8/26/20). "Press Release: Autifony Therapeutics Regains Rights to Clinical Stage Kv3 Programme". Stevenage. |
2020-08-26 |
Cytosurge AG. (8/26/20). "Press Release: Cytosurge Announces Appointment of Thomas Bachmann to Board of Directors". Zurich. |
2020-08-26 |
Eppendorf AG. (8/25/20). "Press Release: Eppendorf AG Records Strong First Half-year 2020. Consolidated Revenue Grows by 6.6% to €403.7 Million in the First Six Months
> Consolidated revenue grows by 6.6% to €403.7 million in the first six months". Hamb |
2020-08-25 |
Bayer AG. (8/24/20). "Press Release: Bayer and Informed Data Systems Inc. (One Drop) Join Forces to Jointly Develop Digital Health Products across Therapeutic Areas". Berlin. |
2020-08-24 |
Qiagen N.V.. (8/21/20). "Press Release: Qiagen Announces New Chairman of Supervisory Board". Venlo. |
2020-08-21 |
Scienion AG. (8/19/20). "Press Release: Cellink Has Entered into an Agreement to Acquire Precision Dispensing Company Scienion AG". |
2020-08-19 |
CureVac B.V.. (8/18/20). "Press Release: CureVac Announces Closing of Initial Public Offering". Tübingen & Boston, MA. |
2020-08-18 |
Evotec SE. (8/18/20). "Press Release: Evotec and Novo Nordisk Form Strategic Alliance to Develop Novel Therapies for Kidney Diseases". Hamburg. |
2020-08-18 |
Bayer AG. (8/18/20). "Press Release: Bayer Names Sara Boettiger as Head of Global Public Affairs, Science and Sustainability for Crop Science Division". Monheim. |
2020-08-18 |
Merck KGaA. (8/17/20). "Press Release: Merck Appoints Liz Henderson as New Regional Vice President, Merck Biopharma APAC". Singapore. |
2020-08-17 |
CureVac B.V.. (8/14/20). "Press Release: CureVac Announces Pricing of Initial Public Offering". Tübingen & Boston, MA. |
2020-08-14 |
Atriva Therapeutics GmbH. (8/11/20). "Press Release: Atriva Announces Closing of € 8.6 Million ($ 10.2 Million) Oversubscribed Convertible Loan". Tübingen. |
2020-08-11 |
Bayer AG. (8/11/20). "Press Release: Bayer to Acquire UK-based Biotech Kandy Therapeutics Ltd. [Not intended for U.S. and UK Media]". Berlin. |
2020-08-11 |
CureVac B.V.. (8/10/20). "Press Release: CureVac Announces Proposed Initial Public Offering of Common Shares". Tübingen. |
2020-08-10 |
Inveox GmbH. (8/10/20). "Press Release: Roche Diagnostics Germany and Inveox Jointly Drive Digital Solutions in Histopathology". Mannheim & Garching. |
2020-08-10 |
NBE Therapeutics AG. (8/10/20). "Press Release: NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors". Basel. |
2020-08-10 |
Bruker Corporation. (8/7/20). "Press Release: Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry". Billerica, MA. |
2020-08-07 |
T-Knife GmbH. (8/6/20). "Press Release: T-Knife Completes € 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies". Berlin. |
2020-08-06 |
Merck KGaA. (8/6/20). "Press Release: Leadership Change within Group Communications at Merck". Darmstadt. |
2020-08-06 |
Evotec SE. (8/5/20). "Press Release: Evotec and Secarna Pharmaceuticals Form Strategic Partnership in the Field of Antisense Therapy". Hamburg & Marburg. |
2020-08-05 |
Affimed N.V.. (8/5/20). "Press Release: Affimed Announces Two New Appointments to Its Supervisory Board". Heidelberg. |
2020-08-05 |
CureVac AG. (8/4/20). "Press Release: CureVac Appoints Dr. Franz-Werner Haas as Chief Executive Officer and Dr. Igor Splawski as Chief Scientific Officer". Tübingen. |
2020-08-04 |
Spindiag GmbH. (8/4/20). "Press Release: Spindiag Appoints Winston Griffin as Chief Financial Officer to Support its Global Finance and Market Expansion Strategy". Freiburg/Breisgau. |
2020-08-04 |
MYR GmbH. (8/4/20). "Press Release: MYR Pharmaceuticals Receives Conditional Marketing Authorization by the European Commission for Hepcludex". Bad Homburg. |
2020-08-04 |
Valo Therapeutics Ltd.. (8/3/20). "Press Release: Valo Therapeutics Appoints Industry Veteran Paul G Higham as CEO". Oxford & Helsinki. |
2020-08-03 |
Siemens Healthineers AG. (8/2/20). "Press Release: Siemens Healthineers Plans Acquisition of Varian". |
2020-08-02 |
MorphoSys AG. (8/1/20). "Press Release: FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)". Planegg & Wilmington, DE. |
2020-08-01 |
PharmaLex GmbH. (8/1/20). "Press Release: PharmaLex Strengthens Its Commercial Organization". Frankfurt. |
2020-08-01 |
BioNTech SE. (7/31/20). "Press Release: BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo (cemiplimab) Combination in Melanoma". Mainz. |
2020-07-31 |
BioNTech SE. (7/31/20). "Press Release: Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate". New York, NY & Mainz. |
2020-07-31 |
Wacker Chemie AG. (7/28/20). "Press Release: Wacker Invests in Amsterdam Biotech Site". Munich & Amsterdam. |
2020-07-28 |
4basebio AG. (7/28/20). "Press Release: 4basebio Informs about Takeover Bid by Sparta AG". Heidelberg & Cambridge. |
2020-07-28 |
BioNTech SE. (7/27/20). "Press Release: BioNTech Announces Closing of $512 Million Underwritten Offering of American Depositary Shares". Mainz. |
2020-07-27 |
BioNTech SE. (7/27/20). "Press Release: Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study". New York, NY & Mainz. |
2020-07-27 |
Biognosys AG. (7/23/20). "Press Release: Boehringer Ingelheim and Biognosys Join Forces on Applying Quantitative Proteomics Tools in Drug Discovery". Biberach & Schlieren. |
2020-07-23 |
T3 Pharmaceuticals AG. (7/22/20). "Press Release: T3 Pharma Raises 25M CHF to Advance Bacterial Cancer Therapy through Clinic". Basel. |
2020-07-22 |
BioNTech SE. (7/22/20). "Press Release: Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. |
2020-07-22 |
BioNTech SE. (7/22/20). "Press Release: BioNTech Announces Pricing of Upsized Underwritten Offering and Terms of Rights Offering". Mainz. |
2020-07-22 |
Max Planck Institute for Biophysical Chemistry (MPI-BPI). (7/22/20). "Press Release: One of the World´s Three Most Powerful High-resolution 1.2 GHz NMR Spectrometers Comes to Göttingen". |
2020-07-22 |
Computomics GmbH. (7/22/20). "Press Release: Computomics Is Member of the German Aerospace Center Network Space2Agriculture". |
2020-07-22 |
Tubulis GmbH. (7/21/20). "Press Release: Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates". Munich. |
2020-07-21 |
Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna. |
2020-07-21 |
BioNTech SE. (7/21/20). "Press Release: Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data". Mainz & New York, NY. |
2020-07-21 |
BioNTech SE. (7/21/20). "Press Release: BioNTech Announces Proposed Public Offerings". Mainz. |
2020-07-21 |
CureVac AG. (7/21/20). "Press Release: CureVac Raises a Total of USD 640 Million in Private Financing Round". Tübingen. |
2020-07-21 |
BioNTech SE. (7/20/20). "Press Release: Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. |
2020-07-20 |
CureVac AG. (7/20/20). "Press Release: GSK and CureVac Announce Strategic mRNA Technology Collaboration". |
2020-07-20 |
Gemoab GmbH. (7/20/20). "Press Release: Gemoab and Intellia Therapeutics Enter into Research Collaboration and Licensing Agreement on Next-Generation Cellular Immunotherapy". Dresden. |
2020-07-20 |
Zur Rose Group AG. (7/16/20). "Press Release: Zur Rose Group Acquires TeleClinic, Germany's Leading Telemedicine Provider". |
2020-07-16 |
[iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. |
2020-07-15 |
Merck KGaA. (7/15/20). "Press Release: Merck Invests € 18 Million in New Life Science Laboratory in Switzerland". Darmstadt. |
2020-07-15 |
Waters Corporation. (7/15/20). "Press Release: Waters Corporation Names Udit Batra President and Chief Executive Officer. Announces Preliminary Second Quarter 2020 Sales". Milford, MA. |
2020-07-15 |
Miltenyi Biotec B.V. & Co. KG. (7/14/20). "Press Release: Miltenyi Biotec Offers Automated and Closed Adherent Cell Culture Solutions on CliniMACS Prodigy". Bergisch Gladbach. |
2020-07-14 |
MorphoSys AG. (7/14/20). "Press Release: MorphoSys' Licensee Janssen Announces Approval of Tremfya (Guselkumab) by U.S. FDA for Treatment of Adults with Active Psoriatic Arthritis". Planegg. |
2020-07-14 |
BioNTech SE. (7/13/20). "Press Release: Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2". New York, NY & Mainz. |
2020-07-13 |
Merck KGaA. (7/13/20). "Press Release: Changes in Merck Executive Board. Belén Garijo appointed Vice Chairman of the Executive Board and Deputy CEO – Udit Batra Leaves". Darmstadt. |
2020-07-13 |
MLM Medical Labs GmbH. (7/8/20). "Press Release: MLM Medical Labs Expands to the US and Nominates Thomas Wollman as Member of the Board". Düsseldorf. |
2020-07-08 |
BRAIN AG. (7/7/20). "Press Release: Change in the Management Board of BRAIN AG. Chief Business Officer Ludger Roedder Is Leaving the Executive Board with Immediate Effect". Zwingenberg. |
2020-07-07 |
Numab Therapeutics AG. (7/7/20). "Press Release: Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases". Wädenswil & Ingelheim. |
2020-07-07 |
Merck KGaA. (7/6/20). "Press Release: Merck Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant". Darmstadt. |
2020-07-06 |